Facebook Instagram X-twitter Linkedin

5-amino-1mq 5mg

Table of Contents

  • Quickstart Highlights

5-Amino-1MQ 5mg dosage protocols focus on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor, researched for its potential role in supporting fat metabolism, preserving lean muscle mass, and enhancing intracellular NAD+ levels. By inhibiting NNMT, 5-Amino-1MQ may help improve cellular energy balance and activate SIRT1 pathways linked to metabolic efficiency. This guide outlines a subcutaneous administration approach optimized for the 5 mg vial format.

  • Reconstitute: Add 1.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical daily range: 2.5–5 mg once daily (subcutaneous)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Support metabolic efficiency via NNMT inhibition, potentially improving fat oxidation and NAD+ availability
  • Schedule: Daily subcutaneous injections; each 5 mg vial typically provides 1–2 days of use, depending on dose
  • Dose Range: 2.5–5 mg once daily
  • Dosing Protocol

Suggested approach for the 5 mg vial format.

  • Start: 2.5 mg once daily to assess tolerance
  • Target: 5 mg once daily
  • Frequency: Once per day (subcutaneous)
  • Vial Duration: One 5 mg vial lasts approximately 1–2 days at standard dosing
  • Timing: Morning administration preferred for metabolic support
  • Mechanism of Action

5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small molecule that selectively inhibits Nicotinamide N-methyltransferase (NNMT). NNMT is an enzyme involved in the methylation of nicotinamide (vitamin B3), which can reduce NAD+ availability when overexpressed—commonly observed in obesity and metabolic dysfunction.

By inhibiting NNMT, 5-Amino-1MQ may help preserve nicotinamide for NAD+ production through the salvage pathway. This can lead to activation of SIRT1 pathways associated with mitochondrial function, fat metabolism, and improved metabolic flexibility. Preclinical research suggests that NNMT inhibition may support resistance to diet-induced weight gain and improve metabolic markers without reducing caloric intake.

  • Potential Benefits & Side Effects

Observations from preclinical and limited clinical literature.

  • May support accelerated healing of tendons, ligaments, muscles, and soft tissue injuries[1][5].
  • Preclinical evidence suggests gastroprotective and anti-inflammatory properties for BPC-157[2].
  • TB-500 promotes wound healing and may reduce scarring through enhanced cell migration[3].
  • Both peptides are generally well tolerated; occasional mild injection-site reactions (redness, itching) may occur with subcutaneous administration.
  • No significant toxicity has been documented up to high doses in animal studies[11][12].